Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent

Autor: Erlinge, David, Andersson, Jonas, Fröbert, Ole, Törnerud, Mattias, Böhm, Felix, Held, Claes, Elek, Candace, Sirhan, Motasim, Oldgren, Jonas, James, Stefan
Zdroj: In American Heart Journal November 2024 277:1-10
Databáze: ScienceDirect